Medical 24 Limited - Limited company accounts 16.3

Medical 24 Limited - Limited company accounts 16.3


08705888 1.10.15 30.9.16 30.9.16 Company accounts Private Limited Company FY false false true false false false false true false A Ordinary 1.00000 Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure087058882015-09-30087058882016-09-30087058882015-10-012016-09-30087058882014-09-30087058882014-10-012015-09-30087058882015-09-3008705888ns12:England2015-10-012016-09-3008705888ns14:PoundSterling2015-10-012016-09-3008705888ns7:Director12015-10-012016-09-3008705888ns7:OrdinaryShareClass22015-10-012016-09-3008705888ns7:OrdinaryShareClass12015-10-012016-09-3008705888ns7:Director22015-10-012016-09-3008705888ns7:Director32015-10-012016-09-3008705888ns7:Director42015-10-012016-09-3008705888ns7:Director52015-10-012016-09-3008705888ns7:Director62015-10-012016-09-3008705888ns7:CompanySecretary2015-10-012016-09-3008705888ns7:RegisteredOffice2015-10-012016-09-3008705888ns7:EntityAccountantsOrAuditors2015-10-012016-09-3008705888ns7:EntityAccountantsOrAuditors2016-09-3008705888ns5:FixturesFittings2015-10-012016-09-3008705888ns5:OwnedOrFreeholdTangibleFixedAssets2015-10-012016-09-3008705888ns5:OwnedOrFreeholdTangibleFixedAssets2014-10-012015-09-3008705888ns7:EntityAccountantsOrAuditors2014-10-012015-09-3008705888ns7:AllEntityOfficers2015-10-012016-09-3008705888ns7:AllEntityOfficers2014-10-012015-09-3008705888ns5:FixturesFittings2015-09-3008705888ns5:FixturesFittings2016-09-3008705888ns5:FixturesFittings2015-09-3008705888ns7:OrdinaryShareClass22016-09-3008705888ns7:OrdinaryShareClass22015-09-3008705888ns7:OrdinaryShareClass12016-09-3008705888ns7:OrdinaryShareClass12015-09-30
REGISTERED NUMBER: 08705888 (England and Wales)















Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 30 September 2016

for

Medical 24 Limited

Medical 24 Limited (Registered number: 08705888)






Contents of the Financial Statements
for the Year Ended 30 September 2016




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Profit and Loss Account 6

Balance Sheet 7

Cash Flow Statement 8

Notes to the Cash Flow Statement 9

Notes to the Financial Statements 10


Medical 24 Limited

Company Information
for the Year Ended 30 September 2016







DIRECTORS: K Coyle
C Coyle
D Harrington
N Poturicich
C Safapour
Ms A L Cooper





SECRETARY: C Coyle





REGISTERED OFFICE: Hygeia House
66-68 College Road
Harrow
Middlesex
HA1 1BE





REGISTERED NUMBER: 08705888 (England and Wales)





AUDITORS: SHERIDAN CLARKE LTD
STATUTORY AUDITORS
BRIDGE HOUSE
25-27 THE BRIDGE
HARROW
HA3 5AB

Medical 24 Limited (Registered number: 08705888)

Strategic Report
for the Year Ended 30 September 2016

The directors present their strategic report for the year ended 30 September 2016.

REVIEW OF BUSINESS
The Directors consider that the profit achieved on ordinary activities before taxation to be satisfactory. The downturn in
turnover on prior years is due to changes within the healthcare sector and the NHS.



2016 2015 2014

Turnover £3,314,016 £ 8,012,542 £2,212,165

Turnover growth (£4,698,526) £5,800,377 £2,212,165

Gross profit margin 31% 30% 30%

Profit before tax 12% 16% 16%

PRINCIPAL RISKS AND UNCERTAINTIES
Medical 24 Limited had a satisfactory year and continue to supply staff to the healthcare sector. Due to the current
economic conditions the Directors are aware of the need to monitor costs and have put policies in place to maintain
stability and the profitability of the business.

It is not considered necessary for an understanding of the development, performance or position of the company's
business to comment here on environmental matters, the entity's employees or social, community and human rights
issues. However, the company is very much aware and respectful of such matters and takes them in to account when
planning and implementing business policy and procedures.

ON BEHALF OF THE BOARD:





D Harrington - Director


26 April 2017

Medical 24 Limited (Registered number: 08705888)

Report of the Directors
for the Year Ended 30 September 2016

The directors present their report with the financial statements of the company for the year ended 30 September 2016.

DIVIDENDS
No interim dividends were paid during the year ended 30 September 2016.

The directors recommend final dividends per share as follows:

Ordinary £1 shares £7,526
A Ordinary £1 shares NIL

The total distribution of dividends for the year ended 30 September 2016 will be £ 752,680 .

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2015 to the date of this
report.

K Coyle
C Coyle
D Harrington
N Poturicich
C Safapour

Other changes in directors holding office are as follows:

Ms A L Cooper - appointed 1 October 2015

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements
in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors
have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting
Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not
approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the
company and of the profit or loss of the company for that period. In preparing these financial statements, the directors
are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-state whether applicable accounting standards have been followed, subject to any material departures disclosed and
explained in the financial statements;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will
continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the
company's transactions and disclose with reasonable accuracy at any time the financial position of the company and
enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for
safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud
and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act
2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have
taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the
company's auditors are aware of that information.

Medical 24 Limited (Registered number: 08705888)

Report of the Directors
for the Year Ended 30 September 2016


AUDITORS
The auditors, SHERIDAN CLARKE LTD, will be proposed for re-appointment at the forthcoming Annual General
Meeting.

ON BEHALF OF THE BOARD:





D Harrington - Director


26 April 2017

Report of the Independent Auditors to the Members of
Medical 24 Limited

We have audited the financial statements of Medical 24 Limited for the year ended 30 September 2016 on pages six to
thirteen. The financial reporting framework that has been applied in their preparation is applicable law and United
Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those
matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent
permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's
members as a body, for our audit work, for this report, or for the opinions we have formed.

Respective responsibilities of directors and auditors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors.

Scope of the audit of the financial statements
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give
reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error.
This includes an assessment of: whether the accounting policies are appropriate to the company's circumstances and
have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by
the directors; and the overall presentation of the financial statements. In addition, we read all the financial and
non-financial information in the Strategic Report and the Report of the Directors to identify material inconsistencies with
the audited financial statements and to identify any information that is apparently materially incorrect based on, or
materially inconsistent with, the knowledge acquired by us in the course of performing the audit. If we become aware of
any apparent material misstatements or inconsistencies we consider the implications for our report.


Opinion on financial statements
In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 September 2016 and of its profit for the year
then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Opinion on other matter prescribed by the Companies Act 2006
In our opinion the information given in the Strategic Report and the Report of the Directors for the financial year for
which the financial statements are prepared is consistent with the financial statements.

Matters on which we are required to report by exception
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you
if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from
branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.




Ms Anna Clarke (Senior Statutory Auditor)
for and on behalf of SHERIDAN CLARKE LTD
STATUTORY AUDITORS
BRIDGE HOUSE
25-27 THE BRIDGE
HARROW
HA3 5AB

26 April 2017

Medical 24 Limited (Registered number: 08705888)

Profit and Loss Account
for the Year Ended 30 September 2016

30.9.16 30.9.15
Notes £    £   

TURNOVER 3,314,016 8,012,542

Cost of sales 2,369,869 5,624,916
GROSS PROFIT 944,147 2,387,626

Administrative expenses 563,251 1,062,346
OPERATING PROFIT 3 380,896 1,325,280

Interest receivable and similar income 1,979 -
PROFIT ON ORDINARY ACTIVITIES
BEFORE TAXATION

382,875

1,325,280

Tax on profit on ordinary activities 4 76,879 272,277
PROFIT FOR THE FINANCIAL YEAR 305,996 1,053,003

CONTINUING OPERATIONS
None of the company's activities were acquired or discontinued during the current year or previous year.

TOTAL RECOGNISED GAINS AND LOSSES
The company has no recognised gains or losses other than the profits for the current year or previous year.


Medical 24 Limited (Registered number: 08705888)

Balance Sheet
30 September 2016

30.9.16 30.9.15
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 6 3,273 4,364

CURRENT ASSETS
Debtors 7 242,315 753,279
Prepayments and accrued income 4,117 -
Cash at bank 332,579 690,315
579,011 1,443,594
CREDITORS
Amounts falling due within one year 8 54,243 473,233
NET CURRENT ASSETS 524,768 970,361
TOTAL ASSETS LESS CURRENT
LIABILITIES

528,041

974,725

CAPITAL AND RESERVES
Called up share capital 9 140 140
Profit and loss account 10 527,901 974,585
SHAREHOLDERS' FUNDS 12 528,041 974,725

The financial statements were approved by the Board of Directors on 26 April 2017 and were signed on its behalf by:





D Harrington - Director


Medical 24 Limited (Registered number: 08705888)

Cash Flow Statement
for the Year Ended 30 September 2016

30.9.16 30.9.15
Notes £    £   
Net cash inflow
from operating activities 1 742,121 1,179,205

Returns on investments and
servicing of finance 2 1,979 -

Taxation (349,156 ) (81,097 )

Equity dividends paid (752,680 ) (366,869 )
(357,736 ) 731,239

Financing 2 - 40
(Decrease)/increase in cash in the period (357,736 ) 731,279


Reconciliation of net cash flow
to movement in net funds 3

(Decrease)/increase in cash in the period (357,736 ) 731,279
Change in net funds resulting
from cash flows (357,736 ) 731,279
Movement in net funds in the period (357,736 ) 731,279
Net funds/(debt) at 1 October 690,315 (40,964 )
Net funds at 30 September 332,579 690,315

Medical 24 Limited (Registered number: 08705888)

Notes to the Cash Flow Statement
for the Year Ended 30 September 2016

1. RECONCILIATION OF OPERATING PROFIT TO NET CASH INFLOW FROM OPERATING
ACTIVITIES

30.9.16 30.9.15
£    £   
Operating profit 380,896 1,325,280
Depreciation charges 1,091 1,451
Decrease/(increase) in debtors 506,847 (200,746 )
(Decrease)/increase in creditors (146,713 ) 53,220
Net cash inflow from operating activities 742,121 1,179,205

2. ANALYSIS OF CASH FLOWS FOR HEADINGS NETTED IN THE CASH FLOW STATEMENT

30.9.16 30.9.15
£    £   
Returns on investments and servicing of finance
Interest received 1,979 -
Net cash inflow for returns on investments and servicing of finance 1,979 -

Financing
Share issue - 40
Net cash inflow from financing - 40

3. ANALYSIS OF CHANGES IN NET FUNDS
At At
1.10.15 Cash flow 30.9.16
£    £    £   
Net cash:
Cash at bank 690,315 (357,736 ) 332,579
690,315 (357,736 ) 332,579

Total 690,315 (357,736 ) 332,579

Medical 24 Limited (Registered number: 08705888)

Notes to the Financial Statements
for the Year Ended 30 September 2016

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and are in accordance with
applicable accounting standards.

Turnover
Turnover comprises the invoiced value of services supplied by the company, all revenue is recognised in the
Financial Statements as soon as the service has been supplied.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings - 25% on reducing balance

Taxation
Current tax, including UK Corporation tax is provided at amounts expected to be paid using the tax rates and
laws enacted by the Balance Sheet date.

Deferred tax is only provided for when material. The Director's have decided that deferred tax is not material this
year, as was the case last year.

2. STAFF COSTS
30.9.16 30.9.15
£    £   
Wages and salaries 382,636 801,709
Social security costs 41,358 94,551
423,994 896,260

The average monthly number of employees during the year was as follows:
30.9.16 30.9.15

Administration 3 3
Sales 3 10
6 13

3. OPERATING PROFIT

The operating profit is stated after charging:

30.9.16 30.9.15
£    £   
Depreciation - owned assets 1,091 1,451
Auditors' remuneration 4,800 5,000

Directors' remuneration 190,388 261,880

Medical 24 Limited (Registered number: 08705888)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2016

4. TAXATION

Analysis of the tax charge
The tax charge on the profit on ordinary activities for the year was as follows:
30.9.16 30.9.15
£    £   
Current tax:
UK corporation tax 76,879 272,277
Tax on profit on ordinary activities 76,879 272,277

Factors affecting the tax charge
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is
explained below:

30.9.16 30.9.15
£    £   
Profit on ordinary activities before tax 382,875 1,325,280
Profit on ordinary activities
multiplied by the standard rate of corporation tax
in the UK of 20% (2015 - 20.500%) 76,575 271,682

Effects of:
Expenses not deductible for tax purposes 304 315
Depreciation in excess of capital allowances - 280
Current tax charge 76,879 272,277

5. DIVIDENDS
30.9.16 30.9.15
£    £   
Ordinary shares of £1 each
Final 752,680 366,869

6. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 October 2015
and 30 September 2016 7,753
DEPRECIATION
At 1 October 2015 3,389
Charge for year 1,091
At 30 September 2016 4,480
NET BOOK VALUE
At 30 September 2016 3,273
At 30 September 2015 4,364

Medical 24 Limited (Registered number: 08705888)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2016

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.16 30.9.15
£    £   
Trade debtors 183,054 753,139
Other debtors 140 140
Tax overpaid 59,121 -
242,315 753,279

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.16 30.9.15
£    £   
Trade creditors 208 4,857
Tax - 272,277
Social security and other taxes 3,502 24,923
Other creditors 45,733 159,134
Accrued expenses 4,800 12,042
54,243 473,233

See note 11 for details regarding Related Parties in Other creditors.

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.16 30.9.15
value: £    £   
40 A Ordinary £1 40 40

Allotted and issued:
Number: Class: Nominal 30.9.16 30.9.15
value: £    £   
100 Share capital 1 £1 100 100

10. RESERVES
Profit
and loss
account
£   

At 1 October 2015 974,585
Profit for the year 305,996
Dividends (752,680 )
At 30 September 2016 527,901

Medical 24 Limited (Registered number: 08705888)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2016

11. RELATED PARTY DISCLOSURES

K. Coyle, C. Coyle, D. Harrington, N. Poturicich, C. Safapour and A. Cooper are also Directors of Mayday
Healthcare Plc, Mayday Direct 24 Plc, Plan B Healthcare Plc, VIP Nursing Limited and Pro Health 24 Limited.
Further, K. Coyle, D. Harrington and A. Cooper are also Directors of Coyle Personnel Plc. At the year end, the
company owed Coyle Personnel Plc £nil, 2015 £ 1,042 and Mayday Healthcare Plc £2,390, 2015
£ 577 for services supplied, these amounts have now been paid.

No trading has been carried out between any of the Related Parties. Kevin Coyle holds the controlling interest in
the company by virtue of ownership of 80% of the shares, his son Christopher owns the remaining 20%. All
dividends were paid to shareholder Directors.

12. RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS
30.9.16 30.9.15
£    £   
Profit for the financial year 305,996 1,053,003
Dividends (752,680 ) (366,869 )
New share capital subscribed - 40
Net (reduction)/addition to shareholders' funds (446,684 ) 686,174
Opening shareholders' funds 974,725 288,551
Closing shareholders' funds 528,041 974,725